Chemotherapy temporarily hinders the body’s immune response, creating a concern that it may interfere with the promising new cancer vaccines being used against brain tumors.
Rats paralyzed due to loss of blood flow to the spine returned to near normal ambulatory function six weeks after receiving grafts of human spinal stem cells (hSSCs), researchers from the University of California, San Diego (UCSD) School of Medicine report.
In the first scientific study of its kind, shark cartilage extract, AE-941 or neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, researchers say.
North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.
GlaxoSmithKline (NYSE: GSK) announced positive data from three key studies on its first-in-class, oral small molecule HER2 kinase inhibitor, Tykerb (lapatinib).
American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment, revealed by researchers.
A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.
Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers.
GEMZAR? (gemcitabine HCl for injection), approved in combination with paclitaxel (Taxol?) in the first-line, post-surgical treatment of metastatic breast cancer, was the subject of a study presented with encouraging results in the pre-surgical treatment of breast cancer.